Last November, Nuritas, the Irish biotechnology company, closed a massive $45 million funding round to help accelerate its global expansion. The round brought the company’s total funding to $75 million and was a statement of confidence from a host of big-name backers including Chicago-based Cleveland Avenue, Grosvenor’s Wheatsheaf Group, and the European Circular Bioeconomy Fund (ECBF). Existing investors such as Bono, Adam Clayton and The Edge as well as Cultivian Sandbox Ventures also participated. The capital injection has shored up the company’s financial position, as evidenced by accounts filed by Nuritas in recent days for the 2021 financial year. When…

Join The Currency

INTRODUCTORY OFFER: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 4,000 exclusive interviews, investigations, and analysis, plus over 460 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.